Daniella Kranjac

Founder • Dynamk Capital

Daniella Kranjac is a Founding General Partner at Dynamk Capital. Daniella led Dynamk Capital’s investments in CellFE Biotech, Envisagenics, FloDesign Sonics (acquired by Millipore Sigma), RoosterBio, Virica Biotech, Xcell Biosciences, and others.

Prior to founding Dynamk Capital, she was CEO and Founder of Dynamk Consulting, providing capital, strategy, and business development consulting to leading life science companies and startups.

Before that, she was an entrepreneur and co-founded Wave Biotech LLC, driving the start-up, growth, and commercialization of highly disruptive technology. As Vice President of the organization, Daniella established a high-growth company with significant brand recognition and led the group to a successful exit and acquisition by GE Healthcare in 2007 (now Danaher/Cytiva).

Also speaking

Alexander Natz

Secretary General • European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

Hanna P. Lesch

Chief Technology Officer • Exothera SA

Sarah Snykers

Senior Director of Operations Europe • Legend Biotech

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.